(a) The board shall promulgate rules regarding the board’s oversight of facilities that manufacture, warehouse, and distribute medical devices. The rules promulgated under this subsection (a) must include the formation of an advisory committee, in accordance with § 4-5-205, composed of medical device industry representatives and a representative of the department of economic and community development.

Terms Used In Tennessee Code 63-10-314

  • Board: means the Tennessee board of pharmacy. See Tennessee Code 63-10-204
  • Device: means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar or related article, including any component part or accessory, that is required under federal or state law to be ordered or prescribed by a person duly authorized. See Tennessee Code 63-10-204
  • Oversight: Committee review of the activities of a Federal agency or program.
  • Representative: when applied to those who represent a decedent, includes executors and administrators, unless the context implies heirs and distributees. See Tennessee Code 1-3-105
(b) The rules promulgated pursuant to this section must be reviewed by the advisory committee every three (3) years to review the advancements of new medical device technologies.
(c) The rules must be promulgated in accordance with the Uniform Administrative Procedures Act, compiled in title 4, chapter 5.
  Previous section
Next section  
 Part 3 Contents